Application Nr Approved Date Route Status External Links
ANDA203020 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Hypertension Irbesartan Tablets Are Indicated For The Treatment Of Hypertension. It May Be Used Alone Or In Combination With Other Antihypertensive Agents. Nephropathy In Type 2 Diabetic Patients Irbesartan Tablets Are Indicated For The Treatment Of Diabetic Nephropathy With An Elevated Serum Creatinine And Proteinuria (>300 Mg/day) In Patients With Type 2 Diabetes And Hypertension. In This Population, Irbesartan Tablets Reduces The Rate Of Progression Of Nephropathy As Measured By The Occurrence Of Doubling Of Serum Creatinine Or End-Stage Renal Disease (need For Dialysis Or Renal Transplantation) (see Clinical Pharmacology: Clinical Studies ).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Irbesartan IRBESARTAN ZINC3872931

Comments